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Introduction
Juvenile Idiopathic Arthritis(JIA) is an inflammatory
chronic disease concerning joints and others structures.
According to International League of Association for
Rheumatology (ILAR) seven subtypes of arthritis can be
defined in relation with the number of joints and the
extra-articular involvement occurring in the first six
months of disease. Although JIA pathogenesis is not
completely clear is known that T-cell activation is a fea-
ture of oligoarticular and polyarticular JIA. The endo-
cannabinoid system is involved in immune regulation by
reducing cells activation, modulating Th1 and Th2 bal-
ance, inhibiting proinflammatory cytokine production.
T-cell and other cellular components of immune system
express cannabinoid receptor 1 and 2 (CB1-CB2).
Objectives
It has been demonstrated that a CB2 common variant,
glutamine-arginine substitution Q63R, differently modu-
lated the EC-induced inhibition of T-cells proliferation.
T lymphocytes from RR homozygotes had two fold reduc-
tion of EC-induced inhibition of proliferation compared to
those from QQ homozygotes, suggesting this CB2 varia-
tion as a risk factor for autoimmune diseases. The aim of
this study is to investigate whether the functional variant
Q63R of CB2 is associated with the susceptibility to oligo/
polyarticular JIA and with its clinical features.
Methods
This study includes 171 children suffering from JIA(124
females;47 males) genotyped for the CNR2 rs35761398
variant causing the substitution Q63R. JIA diagnosis was
made according to ILAR criteria and treatment was
assigned with recommendations of the American College
of Rheumatology. For each patient we evaluated number
of affected joints, age of onset , comorbidities, presence of
autoimmune diseases associated and relapses. The
presence of uveitis was considered a comorbidity. Celiac
disease, thyroiditis and diabetes mellitus were considered
autoimmune disease associated. According to Wallace
criteria any symptom appearing after six months from
remission was considered as relapse of arthritis. 600
healthy children previously genotyped for the CB2 Q63R
functional variant were used as controls. P values less than
0.05 were considered significant. The odds ratio was evalu-
ated considering the presence of at least one single risk
allele (heterozygous QR plus homozygous RR vs homozy-
gous QQ) or two( homozygous RR vs homozygous QQ
and heterozygous QR).
Results
We genotyped 105 oligoarticular and 66 polyarticular JIA
affected children for the CNR2 rs35761398 variant. We
analyzed the same variant in 600 healthy controls. The
allelic frequencies and the genotype distributions of CB2
polymorphism showed a significant difference between
patients and controls (p=0,03;p=0,0001 respectively). The
relative odds ratios (OR) revealed a double risk for devel-
oping oligo/polyarticular JIA in patients with at least one
R63 allele, respect to QQ homozygotes( OR=1.905; C:I
95% 1.06-3.47;p= 0,02). We found a significant associa-
tion of the CB2 Q63R variant with relapse of arthritis
(p=10-4).Finally we found a significant difference in the
genotype distribution of the CB2 Q63R variant between
oligoarticular compared to poliarticular subtype: the per-
centage of RR homozygotes was higher in patients with
polyarticular JIA (52% vs 42%; p=0.04)
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Conclusion
Data found in this study indicate the CB2 receptor as a
possible molecular determinant contributing to susceptibil-
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